Drug-Loaded Nanoparticles Targeted to the Colon With Polysaccharide Hydrogel Reduce Colitis in a Mouse Model

Ballinger, 2008, Adverse effects of nonsteroidal anti-inflammatory drugs on the colon, Curr Gastroenterol Rep, 10, 485, 10.1007/s11894-008-0089-5 Langan, 2007, Ulcerative colitis: diagnosis and treatment, Am Fam Physician, 76, 1323 Truelove, 1960, Systemic and local corticosteroid therapy in ulcerative colitis, Br Med J, 1, 464, 10.1136/bmj.1.5171.464 Reshef, 1992, Systemic effects of rectally administered corticosteroids, Isr J Med Sci, 28, 98 Hebrard, 2009, Investigation of coated whey protein/alginate beads as sustained release dosage form in simulated gastrointestinal environment, Drug Dev Ind Pharm, 14, 1 Lamprecht, 2005, A pH-sensitive microsphere system for the colon delivery of tacrolimus containing nanoparticles, J Control Release, 104, 337, 10.1016/j.jconrel.2005.02.011 Lamprecht, 2005, Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats, J Pharmacol Exp Ther, 315, 196, 10.1124/jpet.105.088146 Leserman, 1981, Cell-specific drug transfer from liposomes bearing monoclonal antibodies, Nature, 293, 226, 10.1038/293226a0 Laroui, 2007, Hyaluronate-covered nanoparticles for the therapeutic targeting of cartilage, Biomacromolecules, 8, 3879, 10.1021/bm700836y Makhlof, 2009, pH-sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model, Eur J Pharm Biopharm, 72, 1, 10.1016/j.ejpb.2008.12.013 Meissner, 2006, Nanoparticles in inflammatory bowel disease: particle targeting versus pH-sensitive delivery, Int J Pharm, 316, 138, 10.1016/j.ijpharm.2006.01.032 Feng, 2009, Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel, Biomaterials, 30, 3297, 10.1016/j.biomaterials.2009.02.045 Yang, 2009, Poly(D,L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer effect, J Nanosci Nanotechnol, 9, 282, 10.1166/jnn.2009.J065 Fukui, 1987, Studies on the promoting effect of lipid-surfactant mixed micelles (MM) on intestinal absorption of colloidal particles, J Pharmacobiodyn, 10, 236, 10.1248/bpb1978.10.236 Kitajima, 1999, Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium, Exp Anim, 48, 137, 10.1538/expanim.48.137 Lamprecht, 2001, Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa, Pharm Res, 18, 788, 10.1023/A:1011032328064 Bachmanov, 2002, Food intake, water intake, and drinking spout side preference of 28 mouse strains, Behav Genet, 32, 435, 10.1023/A:1020884312053 Dalmasso, 2008, PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation, Gastroenterology, 134, 166, 10.1053/j.gastro.2007.10.026 Brzoska, 2008, Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases, Endocr Rev, 29, 581, 10.1210/er.2007-0027 Kannengiesser, 2008, Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease, Inflamm Bowel Dis, 14, 324, 10.1002/ibd.20334 Burd, 1991, Hyaluronan and wound healing: a new perspective, Br J Plast Surg, 44, 579, 10.1016/0007-1226(91)90093-Y Yotsuyanagi, 1987, Calcium-induced gelation of alginic acid and pH-sensitive reswelling of dried gels, Chem Pharm Bull, 35, 1555, 10.1248/cpb.35.1555 Garcia, 1996, Preliminary spherical agglomerates of water soluble drug using natural polymer and cross-linked technique, J Control Release, 40, 179, 10.1016/0168-3659(95)00179-4 Clayton, 1991, The effect of capsule composition on the biocompatibility of alginate-poly-l-lysine capsules, J Microencapsul, 8, 221, 10.3109/02652049109071490 Azab, 2006, Crosslinked chitosan implants as potential degradable devices for brachytherapy: in vitro and in vivo analysis, J Control Release, 111, 281, 10.1016/j.jconrel.2005.12.014 Tozaki, 2002, Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats, J Control Release, 82, 51, 10.1016/S0168-3659(02)00084-6 Mladenovska, 2007, Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles, Int J Pharm, 342, 124, 10.1016/j.ijpharm.2007.05.028 Shi, 2006, Therapeutic potential of chitosan and its derivatives in regenerative medicine, J Surg Res, 133, 185, 10.1016/j.jss.2005.12.013 Xiao, 2005, Assessment of cytotoxicity by emerging impedance spectroscopy, Toxicol Appl Pharmacol, 206, 102, 10.1016/j.taap.2004.10.025 Jain, 2005, The role of nanobiotechnology in drug discovery, Drug Discov Today, 10, 1435, 10.1016/S1359-6446(05)03573-7 Lamprecht, 2003, Multiparticulate systems in the treatment of inflammatory bowel disease, Curr Drug Targets Inflamm Allergy, 2, 137, 10.2174/1568010033484188 Bertholon, 2006, Bioadhesive properties of poly(alkylcyanoacrylate) nanoparticles coated with polysaccharide, J Nanosci Nanotechnol, 6, 3102, 10.1166/jnn.2006.418 Hillaireau, 2007, Encapsulation of mono- and oligo-nucleotides into aqueous-core nanocapsules in presence of various water-soluble polymers, Int J Pharm, 331, 148, 10.1016/j.ijpharm.2006.10.031 Nugent, 2001, Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs, Gut, 48, 571, 10.1136/gut.48.4.571 Luger, 2003, New insights into the functions of alpha-MSH and related peptides in the immune system, Ann N Y Acad Sci, 994, 133, 10.1111/j.1749-6632.2003.tb03172.x Sogias, 2008, Why is chitosan mucoadhesive?, Biomacromolecules, 9, 1837, 10.1021/bm800276d Laroui, 2007, Hyaluronate-covered nanoparticles for the therapeutic targeting of cartilage, Biomacromolecules, 8, 3879, 10.1021/bm700836y Ngamwongsatit, 2008, WST-1-based cell cytotoxicity assay as a substitute for MTT-based assay for rapid detection of toxigenic Bacillus species using CHO cell line, J Microbiol Methods, 73, 211, 10.1016/j.mimet.2008.03.002 Charrier, 2005, ADAM-15 inhibits wound healing in human intestinal epithelial cell monolayers, Am J Physiol Gastrointest Liver Physiol, 288, G346, 10.1152/ajpgi.00262.2004